Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy of Pulmonary Arterial Hypertension (PAH) With Bosentan in Patients With Eisenmenger Syndrome

NCT00266162 is registered in ClinicalTrials.gov with Competence Network for Congenital Heart Defects as lead sponsor.

NCT NCT00266162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00266162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy of Pulmonary Arterial Hypertension (PAH) With Bosentan in Patients With Eisenmenger Syndrome
Lead sponsor
Competence Network for Congenital Heart Defects
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2004
Completion date
February 29, 2008
Enrollment
60
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

eisenmenger syndrome